Justin Fulcher and the Vision Behind RingMD’s Global Reach

The moment Justin Fulcher traces back to the creation of RingMD involves a man in Jakarta holding an Android smartphone while drinking water from the ground. The image was a compressed version of something he had seen across Southeast Asia over several years: consumer technology was everywhere, and basic healthcare access was not. That gap, visible only up close, was the founding logic for what became one of the more widely deployed telehealth platforms in the world.

Framing the Sale as a Continuation

Fulcher had left South Carolina and Clemson University at nineteen to travel Southeast Asia on a three-month plan. The three months became seven years. He built RingMD without institutional backing at the outset investors came to him after the prototype was already functioning. He incorporated the company in Singapore, where the regulatory environment and geographic access to key Asian markets made expansion feasible.

In 2018, Fulcher sold a majority stake in RingMD and spent approximately a year managing the transition. The company’s headquarters moved from Singapore to Boston, and the platform relaunched in the United States in 2019 with a focus on government-grade compliance and institutional clients. He framed the sale as a strategic evolution, not an exit. “This is a continuation of the vision rather than a departure from,” he said. Bringing on partners with capital and positioning to take the platform further was, in his account, about scaling rather than stepping away.

By the time Justin Fulcher departed the company in January 2025, RingMD had logged 1.5 million patient records and maintained a provider network of 10,000 across more than fifty countries. The platform served clients including the Indian government’s Digital India program and the US Indian Health Service. Its compliance certifications FedRAMP Moderate, FISMA, and HIPAA reflected the institutional environment Fulcher had deliberately built toward.

When COVID-19 arrived in early 2020, Fulcher offered a white-labelled version of the platform at no cost to healthcare organizations worldwide, a decision consistent with the approach that had driven the company since its earliest years in Singapore. Visit this page on LinkedIn, to learn more.

Follow for about Judd Zebersky on https://www.instagram.com/justinfulcher/?hl=en